Search

everythinglearnresearchcommunity

for

Search:↓

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Finasteride exposure affects gene expression and anogenital distance in male rat fetuses.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

The conclusion is that metformin is a first-line treatment for PCOS, particularly for restoring ovulation and increasing pregnancy rates, with other treatments depending on specific symptoms.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

Spironolactone is used in dermatology to treat skin conditions related to hormones, but is not safe for pregnant women or men.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

Androgens can both increase body hair and cause scalp hair loss.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

This text talks about how to treat hair loss in women. It suggests different options and stresses the importance of support.

A girl with Becker's nevus syndrome showed good improvement in breast development using spironolactone.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Researchers successfully made new compounds for hormone level tests, but one attempt led to an unexpected product, correcting a past error.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Women with acne and irregular periods had higher active testosterone levels, which could suggest the usefulness of antiandrogen treatment.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Merck will refund the cost of the drug finasteride if it doesn't improve symptoms within six months or if the patient needs surgery within two years.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.